USPTO 2015–2025 USPTO PatentsView US Corporation

Silk Road Medical, Inc.

USPTO PatentsView assignee record - 80 granted patents across 5 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

RSS updates for this company

The verdict

According to USPTO PatentsView, Silk ranks #4,432 of 49,997 tracked US assignees by granted-patent volume, with 80 patents across 5 technology areas.

#4,432
of 49,997 US assignees by volume
Top 47%
by Innovation Score (36.1/100)
14.3
avg claims per patent
-8%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R4432 · US Corporation #4,432 · 80 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-FLAT · BOOK-FULL

  • GRANTS-SMALL 80 grants
  • TOP-DECILE #4,432/49,997
  • PHOTO-FINISH SK Biopharmaceuticals
  • CPC-NARROW A61M · 5 areas
  • INNOV-THIN 36.1/100
  • CLAIMS-RICH 14.3 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-FLAT -8% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: SK Biopharmaceuticals Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Silk

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Silk's Innovation Score is 36.1/100 (top 47% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Silk's grants concentrate

Silk Road Medical, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 96.3% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2019 (14 grants) versus a trough of 4 in 2018. By volume, Silk sits between SK Biopharmaceuticals Co., Ltd. and Tenacious Holdings, Inc..

Silk's three-year grant acceleration

From 2019–2021 to 2022–2024, Silk Road Medical, Inc. moved from 30 to 20 grants (0.67x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Who files at Silk's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Silk holds 80 patents at rank #4,436, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Silk

By rank, the assignees closest to #4,436 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Silk's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Silk, neither rank-band nor same-CPC leaders (those blocks stay above).

Silk's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 47% higher than 53% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

051015 20152016201720182019202020212022202320242025 5
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Silk Road Medical, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 5 6.3%
2016 7 8.8%
2017 9 11.3%
2018 4 5.0%
2019 14 17.5%
2020 6 7.5%
2021 10 12.5%
2022 5 6.3%
2023 4 5.0%
2024 11 13.8%
2025partial year 5 6.3%

Where it ranks

Overall rank by patents

#4,432

of 49,997 tracked assignees

Innovation Score

36.1 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Silk Road Medical, Inc.'s patent record in context - here's where to go next.

  • Silk Road Medical, Inc.'s lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 96.3% of its portfolio - see every assignee active in that class. Explore A61M
  • Ranked #4,432 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Silk Road Medical, Inc. against SK Biopharmaceuticals Co., Ltd., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 36.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.